HLA-E and HIV infectious disease: We employed peptide binding studies, NK functional tests and structural analysis of HLA-E*01:01 and HLA-E*01:03 to test this hypothesis and to address how the HLA-E/NKG2X axis relates to NK activity and consequent clinical outcome of untreated HIV infection.